BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12811528)

  • 1. Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.
    Durrant LG; Chapman MA; Buckley DJ; Spendlove I; Robins RA; Armitage NC
    Cancer Immunol Immunother; 2003 Oct; 52(10):638-42. PubMed ID: 12811528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients.
    Watson NF; Durrant LG; Madjd Z; Ellis IO; Scholefield JH; Spendlove I
    Cancer Immunol Immunother; 2006 Aug; 55(8):973-80. PubMed ID: 16151805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer.
    Simpson JA; Al-Attar A; Watson NF; Scholefield JH; Ilyas M; Durrant LG
    Gut; 2010 Jul; 59(7):926-33. PubMed ID: 20581241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD55 is over-expressed in the tumour environment.
    Li L; Spendlove I; Morgan J; Durrant LG
    Br J Cancer; 2001 Jan; 84(1):80-6. PubMed ID: 11139317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis.
    Rupassara KS; Ponnusamy S; Withanage N; Milewski PJ
    Colorectal Dis; 2006 Jun; 8(5):423-9. PubMed ID: 16684087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
    Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
    Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
    Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
    Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer.
    Miyagawa S; Soeda J; Takagi S; Miwa S; Ichikawa E; Noike T
    Hum Pathol; 2004 Nov; 35(11):1392-6. PubMed ID: 15668897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
    Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
    Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.